首页> 外文期刊>OncoTargets and therapy >Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma
【24h】

Correlation of PDK1 expression with clinicopathologic features and prognosis of hepatocellular carcinoma

机译:PDK1表达与肝细胞癌临床病理特征及预后的关系

获取原文
           

摘要

Objective: To explore the clinical significance of 3-phosphoinositide-dependent protein kinase-1 (PDK1) expression in hepatocellular carcinoma (HCC) and its association with clinicopathologic features and prognosis in HCC patients. Materials and methods: A total of 128 HCC patients who received radical resection were enrolled from Wenling Maternal and Child Health Care Hospital between May 2005 and December 2008, and tumor and adjacent tissue samples were collected. Expression of PDK1 was detected by immunohistochemistry method. Correlation of PDK1 expression with clinicopathological features and prognosis was determined by Spearman’s correlation analysis. Impact of expression of PDK1 on overall survival and recurrence was determined by Kaplan–Meier analysis. Results: Immunohistochemistry results showed that PDK1 expression in HCC tissues was significantly higher than that in the corresponding adjacent cancer tissues. Univariate analysis showed that PDK1 messenger RNA expression can predict time to recurrence with diagnostic significance ( P =0.001). Univariate analysis showed that alpha-fetoprotein level, tumor number, tumor encapsulation, microvascular invasion, and tumor–node–metastasis stage were also unfavorable prognostic variables for recurrence ( P <0.05). Kaplan–Meier analysis showed that overexpression of PDK1 correlates with significantly shorter postoperative overall survival and higher recurrence rates (hazard ratio =2.68; 95% confidence interval: 2.46–4.42, P =0.001) in HCC patients after curative resection. Conclusion: Our study indicated that PDK1 may serve as a candidate pro-oncogene and a potential prognostic biomarker for HCC.
机译:目的:探讨3-磷酸肌醇依赖性蛋白激酶-1(PDK1)在肝细胞癌(HCC)中的表达及其与肝癌临床病理特征和预后的关系。材料与方法:2005年5月至2008年12月,共收治温岭妇幼保健院128例行根治性切除术的HCC患者,并收集肿瘤及邻近组织样本。通过免疫组织化学方法检测PDK1的表达。通过Spearman相关分析确定了PDK1表达与临床病理特征和预后的相关性。通过Kaplan–Meier分析确定了PDK1表达对总体生存和复发的影响。结果:免疫组织化学结果显示,PDK1在肝癌组织中的表达明显高于相应癌旁组织。单因素分析表明PDK1信使RNA的表达可以预测复发时间,具有诊断意义(P = 0.001)。单因素分析显示,甲胎蛋白水平,肿瘤数目,肿瘤包囊,微血管浸润以及肿瘤-淋巴结转移阶段也是复发的不利预后变量(P <0.05)。 Kaplan–Meier分析表明,治愈性切除后HCC患者PDK1的过表达与术后总体生存期明显缩短和复发率较高(危险比= 2.68; 95%置信区间:2.46-4.42,P = 0.001)相关。结论:我们的研究表明PDK1可能作为候选癌原基因和潜在的肝癌预后生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号